Drug manufacturers and importers in Nigeria have identified the forex crisis and the persistent depreciation of the naira against foreign currencies as the primary factors driving the continuous rise in drug prices.

Speaking to Pharmanews in separate interviews, they commended the Federal Government for removing tariffs and duties on pharmaceutical products but warned that the forex crisis might negate the benefits of this policy unless the government provides a lasting solution.

The Managing Director of May & Baker PLC, Pharm. Patrick Ajah, expressed concern over the impact of the forex crisis on pharmaceutical manufacturing in Nigeria. While lauding the removal of tariffs and duties on pharmaceutical products, he urged the government to urgently address the forex issue.

“There is a limit to what companies can do regarding the rising cost of drugs. Most of the materials used in drug production, such as active pharmaceutical ingredients (APIs), are imported, and with the current forex situation, companies have little room to manoeuvre. As long as the naira remains as devalued as it is, if the government doesn’t address the forex problem, the prices of drugs and other products will continue to rise persistently,” Ajah said.

He added, “Companies are incurring losses. Two years ago, the exchange rate was N461 to $1. Now, it is about N1,600–N1,700, a more than 300 per cent increase. Drug manufacturers are struggling to keep prices steady. Without government intervention, things will remain expensive for a long time.”

The General Secretary of the Indian Pharmaceutical Manufacturers and Importers in Nigeria (IPMIN), Prasenjit Banerji, highlighted forex as the main reason for soaring drug prices in Nigeria. He suggested that the best option would be to have zero duty on finished pharmaceutical goods and to accept direct trading in Indian Rupees.

Pharm. Ade Popoola, managing director of Real Pharmaceuticals Limited, pointed out that the rising cost of drugs in Nigeria is primarily due to the exchange rate rather than tariffs and duties, which are 5 per cent and 10 per cent, respectively.

“The removal of 10 per cent duty or tariff may not have a significant impact if the exchange rate remains at N1,600–N1,700 to $1. To truly reduce drug costs, the government should provide a special exchange rate for pharmaceutical transactions,” he stated.

Dr Lolu Ojo, managing director of Merit Healthcare Limited, echoed these sentiments, emphasising that the devaluation of the naira is a major driver of rising drug costs. He noted that Nigeria’s economy is heavily import-dependent, and foreign exchange plays a crucial role in international trade. With the naira losing much of its value, prices of imported products, including medicines, have inevitably risen.

Ojo recommended addressing systemic inefficiencies to revitalise the economy and suggested bulk purchases backed by forex for essential items like medicines.

The Chairman of the Association of Industrial Pharmacists of Nigeria (NAIP), Pharm. Ken Onuegbu, also commended the removal of tariffs and duties, noting its potential to boost local production capacity. However, he stressed that the forex crisis, alongside the cost of APIs, machinery, and regulatory fees, significantly impacts drug prices.

“There are multiple factors contributing to the rising cost of drugs. To achieve affordable prices, all these challenges must be addressed. For instance, NAFDAC’s Good Manufacturing Practice (GMP) inspection fee is calculated at prevailing forex rates, which adds millions of naira to production costs,” he explained.

NAFDAC’s GMP inspection fee, currently about $11,000, was cited as a significant burden on manufacturers and importers, who often pass this cost onto consumers. Onuegbu called for special forex legislation and considerations for medicines.

Prof. Lere Baale, President of the Nigeria Academy of Pharmacists, described the forex crisis as having a profound impact on the pharmaceutical industry. He highlighted the rising costs of importing raw materials, APIs, and finished products, which has made healthcare less affordable for Nigerians.

To address the forex issue, Baale proposed promoting local manufacturing by reducing dependency on imported raw materials and finished products. He suggested investing in infrastructure and technology to support local production and encouraging public-private partnerships to establish local API manufacturing capabilities, which would reduce reliance on imported ingredients.

Baale also advocated for a dedicated forex window for pharmaceutical companies prioritising essential drug production. He suggested that the Central Bank of Nigeria (CBN) could provide such companies with access to foreign currency at favourable rates, alleviating the financial strain caused by exchange rate fluctuations.

He further recommended the establishment of a Forex Stabilisation Fund to support firms affected by forex volatility. By stabilising the forex supply to critical industries like pharmaceuticals, the fund could help reduce the impact of currency devaluation on medicine costs.

“Addressing the forex challenge in Nigeria’s pharmaceutical industry requires policy interventions, investments in local capacity, and strategic partnerships. By promoting local production, establishing dedicated forex windows, and strengthening the supply chain, Nigeria can mitigate forex volatility and ensure affordable medicines for all,” Baale concluded.

Pharm. Taofik Odukoya, a leading Nigerian pharmacist and founder of Vanguard Pharmacy—a prominent chain of retail pharmacies with 11 branches nationwide—has called on the Federal Government to address critical challenges affecting community pharmacies. These include escalating drug costs, the menace of counterfeit medicines, and the increasing burden of chronic disease management.

Speaking during the opening ceremony of the 97th Annual National Conference of the Pharmaceutical Society of Nigeria (PSN) in Uyo, Akwa Ibom State, Odukoya highlighted the pressing need for government intervention to ensure the sustainability of community pharmacies and enhance healthcare delivery across the country.

The Vanguard Pharmacy founder identified the rising cost of healthcare, particularly medications, as a significant barrier to accessing essential treatments for many Nigerians, especially those from low-income backgrounds. He urged the Federal Government to implement affordable pricing policies and provide support to local pharmacies to ensure equitable access to essential medicines.

“We need the government to facilitate the creation of a more cost-effective healthcare system. Only through strategic intervention can we ensure that essential medicines are affordable for everyone,” Odukoya stated.

Odukoya also bemoaned the proliferation of counterfeit drugs, which jeopardise patient safety and erode trust in the pharmacy profession. He called on the government to bolster regulatory frameworks and enforcement mechanisms to curb the circulation of fake medicines in Nigeria.

“The issue of counterfeit drugs is rampant and remains a major safety concern. We need more robust laws and better enforcement to protect Nigerians from the dangers of fake medicines,” he noted.

Odukoya disclosed that, to combat this issue, Vanguard Pharmacy has taken proactive measures, such as sourcing directly from authorised distributors and employing drug verification processes. Odukoya, however, stressed that systemic change requires greater government involvement, including the creation of a national database and improved drug traceability systems.

“At Vanguard, we’re committed to the fight against counterfeit drugs. Ensuring patient safety is central to our mission,” he affirmed.

Odukoya further addressed the increasing burden of chronic diseases like diabetes, hypertension, and cardiovascular conditions on Nigeria’s healthcare system. While community pharmacies, including Vanguard, play a vital role in managing these conditions through services like Medication Therapy Management (MTM) and Disease Management Programmes (DMPs), he emphasised the need for government intervention to scale these efforts.

“Chronic diseases are on the rise, and while community pharmacies can offer critical care, the government must take a leading role in expanding these services and ensuring that all Nigerians have access to them,” Odukoya stated.

He also highlighted the importance of addressing the root causes of chronic diseases through public health campaigns focused on prevention, education, and early detection.

Odukoya equally pointed out other challenges, including limited access to financing, a shortage of skilled workers, and regulatory hurdles, all of which impede the growth and effectiveness of community pharmacies.

“We need more government support to boost funding and create an environment that allows pharmacies to thrive,” he urged. He also called for reforms to the National Health Insurance Scheme (NHIS) to ensure better coverage for community pharmacy services.

“There is a need for reforms to ensure that community pharmacy services are better covered under NHIS,” he argued, stressing that such changes would significantly improve healthcare delivery in Nigeria, particularly in underserved and rural areas.

Reiterating the vital role of community pharmacies in Nigeria’s healthcare system, Odukoya called on the government to actively support these pharmacies in delivering essential services. He emphasised that with adequate support, community pharmacies could drive transformative change in the country’s healthcare sector.

“The government must play a more active role in supporting community pharmacies to ensure they can deliver essential healthcare services,” he said.

-Commissions 12-Unit Toilet Facility in Pry School

In a bid to improve hygiene and education in local communities, the Rotary Club of Lagos Prime, Ikeja, District 9112, has inaugurated newly renovated Pupils’ Toilet facility at Bola Memorial Primary School, Lagos.

The commissioning ceremony, held on 21 November 2024, underscores Rotary’s global commitment to disease prevention, water sanitation, hygiene, and basic education.

Speaking at the event, the Charter President, Rotarian (Pharm.) Gbenga Olubowale, highlighted the initiative’s dual focus on health and education. He emphasised the importance of addressing community needs to ensure a conducive learning environment for children.

“We are not only preventing diseases but also ensuring these children grow healthy and study in a conducive environment,” he said.

The revamped facilities include 12 rehabilitated toilets and water storage drums to guarantee uninterrupted access to clean water.

According to Olubowale, this project reflects Rotary’s guiding principle of “service above self” by stepping in where government resources may be insufficient. He urged the school and local authorities to ensure proper maintenance of the facilities to inspire similar interventions in the future.

Representing the Lagos State Government at the event, Mr Afolabi Awobuyide, head of section, Planning, Research and Statistics, Ikeja Local Government Education Authority, commended the Rotary Club for its impactful initiative.

He stressed the importance of collaborative efforts between the public and private sectors to achieve sustainable development. “The government cannot do it all alone. Clubs like Rotary are showcasing how partnerships can create a better world,” he remarked.

The Headmistress of Bola Memorial Primary School, Mrs Cecilia Sipeolu expressed profound gratitude to the Rotary Club, describing the renovation as transformative for the school’s environment. “We will never forget the great impact you have made,” she stated, adding that the improved facilities would significantly enhance the well-being of students and staff.

The event also highlighted Rotary’s broader goals of preventing diseases and promoting hygiene. The upgraded sanitation infrastructure aims to reduce infections among students, enabling them to focus on their education in a healthier setting.

As the ceremony concluded, Rotary representatives reaffirmed their commitment to sustaining the partnership with the school and exploring additional avenues for support. “Our profit lies in the satisfaction of seeing these children thrive,” one of the speakers noted.

This intervention by the Rotary Club of Ikeja exemplifies its dedication to creating lasting value in communities through targeted actions that address critical gaps in health and education.

Pharmacists have been urged to make extra effort in ensuring that medicines are affordable and also available to all Nigerians irrespective of their sex, location or socio economic status at all times.

The call came up on Thursday at the 7th edition of Ladipo Mobolaji Abisogun-Afodu Annual Lecture in Pharmacy, held at the Old Great Hall, College of Medicine, University of Lagos, Idi-Araba, Lagos State.

The title of the 7th annual lecture is “Medicine Affordability and Accessibility in a Challenging Economy: the Role of the Pharmacy Profession”.

Speaking at the event, the Founder and Chief Executive Officer, Fidson Healthcare PLC, Dr Fidelis Ayebae, who was the chairman of the event congratulated the board of trustees of the annual lecture for their consistency and keeping the flag flying. He also commended the Omololu-Mulele estate for their endowment that made the annual lecture possible.

Commenting on the title of the lecture, Ayebae who was ably represented by an executive director of the company, Mr Olugbenga Olayeye lamented the current economic challenges in the country, saying it is very unusual.

He pointed out that even in view of the current economic challenges in the country, medicine affordability is very critical, stressing that the country needs to give proper attention to medicine security. He noted a nation cannot achieve sound health without medicine, which underscores the importance of medicine affordability.

He decried that packaging materials take the lion share of the cost of drug production in Nigeria today, hence there is need for creative ways of producing packaging materials locally through collaboration between the academia and the industry. He also said as much as there is a need to make medicines affordable to all, it is also imperative to make the medicine accessible to everyone at all times and locations without compromising the original quality.

The Chairman, Board of Trustee, Ladipo Mobolaji Abisogun-Afodu Annual Lecture in Pharmacy, Prof. Oluwole Familoni, in his remark, noted that the annual lecture has become a veritable platform to discourse important pharmacy and health related national issues, stressing that there is need to put frantic effort in place to ensure that medicines are affordable and accessible to all Nigerians.

In her remark, the Vice-Chancellor, University of Lagos, Prof. Folashade Ogunsola appreciated the Omololu-Mulele estate for sustaining the annual lecture, noting that the 7th edition is to further charge stakeholders and state actors on the need to tackle some of the challenges in the health sector.

The VC, ably represented by Prof. Familoni said “Indeed the country is undergoing a phase but I hope we will turn the outcome of this lecture into action”.

Delivering the 7th Annual Lecture, the guest lecturer, who is the Provost, College of Pharmacy, Afe Babalola University, Ado Ekiti (ABUAD), Professor Mbang Femi-Oyewo pointed out that pharmacists have pivotal roles to play in ensuring drug affordability and accessibility in every nation globally.

Quoting a former American President, J.F Kennedy, Prof. Femi-Oyewo said Pharmacists are an indispensable link in the healthcare system, such that if there is no one, there will be need to invent one. She said the statement was reinforced by a former Director General of World Health organisation (WHO), Dr Hiroshi Nakajima, who said in 1989 that “without drugs, a health service has no substance and no credibility”.

The guest lecturer describes medicine as any substance, other than food, used to prevent, diagnose, treat, or relieve symptoms of a disease or abnormal condition. She explained that medicine affordability is how feasible an individual or society finds it to pay for a drug; stressing that socio economic factors such as income level, poverty and social inequality can significantly impact medicine affordability. She pointed out that there is little value in new drugs that patients cannot afford and there is no value in drugs that do not exist.

Medicine accessibility on the other hand, according to the professor, is the reasonable ability of people to get the medicines they need to achieve health, noting that such access is deemed to be part of the right to health.

The speaker pointed out that Nigeria is currently facing many economic challenges that threaten its growth prospects and stability. She also noted that economic challenges play a significant role in medicine availability, noting that creation of more jobs and investing in infrastructure can help to curtail the challenges.

The lecturer said the primary mission of the pharmacy profession is to have a positive impact on the provision of public health services by ensuring the safe and effective use of medications. The practice of pharmacy, according to the professor, includes dispensing of prescription drugs, administration of mediation, review of drug regimens, provision of patient counseling among others.

She added that pharmacists play an essential role in improving accessibility of drugs, especially by bridging the gap between the pharmaceutical companies and underserved communities and advocating for community pharmacies in remote areas. She pointed out that pharmacists play important roles in improving medicine distribution channels as well as advocacy and influencing policy.

“As pharmacists, our expertise, advocacy, innovative and collaborative practices are key to tackling the challenges facing drug availability and accessibility, and improving patients’ outcomes. Pharmacists should be involved in healthcare policies that support the sustainable availability of drugs, strengthen the pharmaceutical supply chain and leverage on technology. Together we can make a difference”, Prof Femi-Oyewo said.

The Dean, Faculty of Pharmacy, University of Lagos, Prof. Gloria Ayoola, in her goodwill message, stated that the event is a testament to the enduring legacy of Pharmacist Ladipo Mobolaji Abisogun-Afodu and the exceptional foresight of his daughter, late Chief (Mrs) Abibola Aina Omololu-Mulele, whose generosity endowment has made the annual lecture possible.

“This year’s theme “Medicine Affordability and Accessibility in a Challenging Economy: the Role of Pharmacy Profession” resonates deeply in today’s complex healthcare landscape. The economic realities we face demand innovative and sustainable solutions to ensure that lifesaving medicines are within the reach of all. As pharmacists, we stand uniquely positioned to bridge the gap between pharmaceutical advances and patients’ access”, Prof. Ayoola said.

The Managing Director, Pharma Solutions, Pharm. Olabisi Oyeleye, who was a guest of honour at the event charged pharmacists to think out of the box. She said “we have talked about many challenges, but I can see many opportunities.

“As a pharmacist, there are different areas you venture into. You just have to start somewhere, just change your mindset, Pharmacists are intelligent. Don’t be narrow minded, go all out and dare it, you can start small”, Pharm. Oyeleye charged pharmacists.

On his part, the chairman of the event planning committee, Prof. Emmanuel Nwanolue Anyika, while appreciating the Omololu-Mulele family and guests that graced the occasion, urged pharmacists to unleash their potential toward making drugs available and accessible to all Nigerians.

The high point of the event was the announcement of the winner of the 5th Ladipo Mobolaji Abisogun-Afodu Research Grant Award Competition in Pharmacy, which is endowed by late Chief (Mrs) Abibola Aina Omololu-Mulele.

The winner of the 5th research grant award, which came with N2, 000, 000, is Pharm. Dr Bamisaye Olaofe Oyawaluja, a lecturer at the department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Lagos. The cheque was presented to the winner at the event. The title of the proposed research is “Artificial Intelligent and Pharmacophore Modelling as a Tool to Improve Access to Medicine to Enhance Quality of Patient’s Life”.

While speaking shortly after presenting the grant cheque to the winner, representative of the Omololu-Mulele, Mrs M.A Sasegbon commended the winner as well as the past winners who have taken their time to engage in research works. She also reiterated the commitment of the family to the grant in subsequent years.

-Charge Local Drug Manufacturers on Quality, Accessible Medicines

An outpouring of accolades greeted the former President of the Pharmaceutical Society of Nigeria (PSN) and the Honorary Consul-General of Pakistan in Nigeria, Pharm. Ahmed I. Yakasai, at the unveiling of his book titled “The Pharmaceutical Industry and Drug Production in Nigeria”, on Thursday, 21 November, 2024.

The book launch, held at the Sheraton Hotel, Ikeja, sparked vigorous discussions on fostering a vibrant and self-sufficient pharmaceutical industry in Nigeria, capable of delivering quality, homegrown medicines for national and international consumption. The event was attended by top government officials, regulatory agencies, pharmaceutical industry stakeholders, and the Kano Emirate.

Prince Julius Adelusi-Adeluyi, former minister of health and chairman of the occasion, commended the author for his perseverance in researching the Nigerian pharmaceutical industry’s history, highlighting the data that charts a way forward for the sub-sector. He asserted that embracing industrialisation alongside necessary policies is crucial for Nigeria to escape its current challenges.

Adelusi cited the visionary leadership of the incumbent Indian president, who initiated a new vision for the country, revolutionising India’s economy and making it the fourth-largest pharmaceutical manufacturer worldwide. “We have about 130 manufacturing units all over the country. But that’s enabling the rest of the world. But India has 3,000 drug companies and 10,000 manufacturing companies.

“We have to do something to not let ourselves down. Don’t just talk about it. Show the government that we are ready and willing. If we don’t go the industrialisation way, we’ll find out whether they create the fifth or sixth world. We’ll still be in the sixth world. Maybe not the sixth. So I think this industrializstion is it. This book should urge us to participate. But heaven helps those who help themselves,” he quipped.

The Director General of NAFDAC, Prof. Moji Adeyeye, also praised the author’s commitment to gathering accurate data for the book, despite the challenges encountered during its writing and publication. “I want to seize this opportunity to commend Alhaji Yakasai and my sister, the wife, for taking the risk to write this book. Taking the time to write the book, and making us all proud. He spent time to gather data and spent time to publish data,” she said.

Adeyeye urged all stakeholders and policymakers to read the book and utilise the data provided for the development of the pharmaceutical subsector. She challenged local pharmaceutical manufacturers to produce quality and accessible medicines, stating, “You are not just making for us. Yes, we want you to make good quality, but we want you to be able to sell, by linking to other countries. We have to link to the world to increase our GDP and decrease unemployment. I challenge you to make quality products that also have a bioequivalence study,” Adeyeye emphasised.

Prof. Lere Baale, the book reviewer, described Ambassador Yakasai as a highly respected figure in the Nigerian pharmaceutical industry who leverages his extensive experience for a thoughtful exploration of the sector’s critical role in the country’s healthcare and economy. He highlighted Yakasai’s significant contributions throughout his career, including his roles as co-founder of Taobat Pharma Industries Ltd, pioneer chairman of the Board of Directors of Evans Baroque Ltd, and various advisory positions.

Reviewing the book, which encompasses four thematic areas—local drug manufacturing, regulatory challenges, public health impact, and global integration—Baale noted that it provides a comprehensive historical background of Nigeria’s pharmaceutical industry, tracing its development from colonial times to the present. He pointed out the book’s core theme of transitioning from dependence on imported drugs to local manufacturing, emphasising the necessity for Nigeria to enhance its drug production capabilities.

In the book, he said Yakasai elaborates on government and private sector efforts to encourage local drug production and reduce reliance on potentially costly and quality-compromised imported pharmaceuticals. The book also examines the policy framework surrounding Nigeria’s pharmaceutical industry, including initiatives like the National Drug Policy and the role of NAFDAC.

Applauding Yakasai’s efforts, Emir of Kano, Alhaji Aminu Ado Bayero, described him as a worthy ambassador of the Kano Emirate. He remarked that the book serves not only the pharmaceutical industry but also as a valuable tool for nation-building.

Prof. Omotayo, DG of the National Institute for Policy and Strategic Studies (NIPSS) expressed joy at Yakasai’ s accomplishment, recounting how they encouraged him during the writing process. “We told him not to stop at anything but a public presentation of the book, which has come to fruition,” he said.

Expressing gratitude to all attendees, the author shared that his passion for a prosperous pharmaceutical industry motivated him to write the book, aiming to create a new path for the sub-sector. He announced that proceeds from the launch would be directed toward the education of the girl child in Kano, addressing the region’s high population of out-of-school children.

Top among the dignitaries that attended the occasion were, Prince Julius Adelusi-Adeluyi, former minister of health; Prof. Moji Adeyeye, DG, National Agency for Food and Drug Administration and Control (NAFDAC); Dr Salma Ibrahim Ana’s, special adviser to the president on health; Senator Malam Ibrahim Shekarau, former minister of health; Pharm. Tanko Ayuba, president, PSN; Pharm. (Hajiya) Wosilat Giwa, chairman, Pharmacy Council of Nigeria (PCN).

Others were, Members, PSN College of Past Presidents; Prof. Ayo Omotayo, DG, National Institute for Policy and Strategic Studies (NIPSS); Emir of Kano, Alhaji Aminu Ado Bayero; Prof. Lere Baale, CEO, Business School Netherlands International, and president, Nigeria Academy of Pharmacy, as the book reviewer; Pharm. (Sir) Ifeanyi Atueyi, immediate past vice-president, NAPharm, and publisher, Pharmanews, among others.

The Association of Resident Doctors, Nnamdi Azikiwe University Teaching Hospital, Anambra State, has advocated for telemedicine following the rising insecurity in the country.

The association made the call at the opening ceremony of the 2024 Health Week in Nnewi on Wednesday.

The theme of the AGM was “Future Trends In Healthcare: Preparing for Tomorrow’s Challenges.”

President of ARD-NAUTH, Dr Chiemezie Agbanu, said the need had become necessary for doctors and patients to interact more without physically coming together through telemedicine practice.

He said this would enable the patient to access the doctor and receive health services through communication technology without unnecessary exposure to the threat of insecurity.

“One of the challenges we have in the country today is insecurity, and one of the future trends in medical practice is telemedicine which informed the choice of our theme.

“With telemedicine, doctors can talk to their patients and render some level of services without necessarily coming together physically; this will help reduce the risk of insecurity to both doctors and patients.

“Other future trends in medicine are the use of Artificial Intelligence and Robots in surgery. We know we are not there yet but we hope that the level of infrastructure will be put in place by the government to enhance efficiency in the sector,” he said.

Earlier in his remark, the Chairman of the occasion, Prof. Chukwuemeka Ezeama, said no doctor would function optimally in an environment where he was not sure of returning safely after work.

Ezeama, a consultant obstetrician and gynecologist at NAUTH described resident doctors as critical components of the healthcare delivery chain as a link between students and consultants.

He urged the doctors to stand together as a unit for better collective interest as well as remain an active and cordial relationship with their senior colleagues.

In his goodwill message, Prof. Joseph Ugboaja, the chief medical director of NAUTH, said the theme of the event was apt as it would help to leverage available innovations in view of the emerging challenges in the nation’s healthcare system.

Ugboaja, who was represented by Dr Dubem Onyejiaka, a chief medical adviser said NAUTH was appreciative of the collaboration and tireless effort of the resident doctors towards achieving its commitment to excellence in healthcare delivery.

The CMD said he was committed to the welfare of ARD members through payment and upgrade of areas, provision of a conducive working environment, allocation of space for the ARD lounge and ensuring unhindered career progression,” he said.

The health week continues with a research symposium, medical outreach, the Annual General Meeting, and the election of a new executive committee.

NAN

The closing banquet of the 97^th Annual National Conference of the Pharmaceutical Society of Nigeria (PSN) was a shining moment for Air Commodore David Olumuyiwa Babalola as he bagged three awards/honours.

Babalola, a consultant clinical pharmacist in the Nigerian Air Force (NAF) won the Biogenerics Integrity Award for pharmacists in public hospital, the Pfizer Excellence Award, as well as the Fellowship of the Pharmaceutical Society of Nigeria (FPSN).

The Air Commodore was announced the winner of the awards at the closing banquet of the 97th Annual National Conference of the Pharmaceutical Society of Nigeria (PSN), held from 4-9 November, 2024, in Uyo, Akwa Ibom State.

The Biogenerics Integrity Award for pharmacists in public hospitals celebrates excellence in patient care, career achievements, innovations, professional service and leadership among others in public hospitals. The award currently has N1 million cash value.

According to the chairman of the award committee, 15 nominees were received for the award. All the nominees were screened after which Air commodore Babalola beat others to emerge winner of the award.

Babalola was also one of four winners of the Pfizer Excellence Award, which recognises outstanding contributions in hospital and community pharmacy. The award has a ₦250,000 cash value, a plaque, and a certificate.

He was also announced to have been conferred with the Fellowship of the Pharmaceutical Society of Nigeria (FPSN), the highest honour awarded to pharmacists in Nigeria, in which its investiture ceremony is expected to come up early 2025.

Reacting to the honours, Babalola expressed gratitude to Biogenerics Nigeria Ltd and Pfizer Nigeria, sponsors of the awards. While thanking the PSN leadership for their efforts towards lifting the Pharmacy profession, Babalola expressed profound gratitude to the Chief of the Air Staff, Air Marshal Hasan Bala Abubakar, for creating the enabling environment for pharmacists in the NAF.

He also commended the Chief of Air Staff for approving the implementation of the Pharmacists Consultant Cadre in the air force.

Babalola is the first pharmacist in the Nigerian Air Force to attain the rank of air commodore. He’s also the first pharmacist in the Nigerian Armed Forces to have won the Biogenerics Integrity Award as well as the Pfizer award since inception till date.

The European Union (EU) and the Enugu State Government have inaugurated a N3.33 billion Solar for Health Project to provide electricity to 25 Primary Healthcare Centres (PHCs) in the state.

The project, launched under the EU’s Nigeria Solar for Health Programme (NISHP), aims to provide 24-hour solar-powered electricity to healthcare facilities in Enugu and four other states—Ogun, Plateau, Abia, and Akwa Ibom—between 2024 and 2027.

Speaking at the launch held at the Old Government Lodge, Enugu, on Tuesday, the Head of Green and Digital Economy for EU Nigeria and ECOWAS, Inga Stephanowicz, said the initiative addresses the lack of basic amenities in primary health centres.

“Enugu is the first state to volunteer and commit the necessary counterpart fund of N1 billion, securing N3.33 billion from the EU for this project. This intervention aligns with the UN Sustainable Development Goals (SDGs), particularly in providing basic health services and electrification,” she said.

Stephanowicz added that the project would also power small businesses and telecom infrastructure around the health centres to enhance their functionality.

Governor Peter Mbah of Enugu State, represented by the Secretary to the State Government, Chidiebere Onyia, described the project as a significant step toward achieving the SDGs and improving healthcare delivery.

“Our commitment to improving healthcare and addressing energy access challenges is evident in this partnership. This initiative ensures uninterrupted energy supply to our primary healthcare facilities, directly impacting the lives of our citizens,” Mbah stated.

The EU’s Programme Manager for Energy Access, Godfrey Ogbemudia, noted that the initiative aligns with the EU’s commitment to expanding renewable energy access in Nigeria.

He revealed that the EU had invested €20 million in Nigeria’s power sector between 2008 and 2020 and committed an additional €37 million to new energy access programmes from 2021 to 2027.

Senior Stakeholder Engagement Manager for NISHP, Tinyan Ogiehor, emphasized the project’s long-term sustainability, which includes integrating productive load users and collaboration with local businesses.

He disclosed that the EU would provide solar PV systems, batteries, and inverters for at least 25 health facilities spread across Enugu’s 17 local government areas.

The Enugu State Solar for Health Project Steering Committee, led by the state’s Commissioner for Health, Emmanuel Obi, will oversee the project’s management and ensure its sustainability.

NAN reports that the EU’s NISHP seeks to electrify over 100 healthcare facilities across the five participating states to strengthen the country’s healthcare system.

NAN

A Consultant Urologist, Dr Odezi Otobo, says there is no medical or urological evidence having regular sex and ejaculation reduces a man’s risk of coming down with prostate cancer.

Otobo, who works with the University of Calabar Teaching Hospital, said this at a medical outreach for men organised by Asi Ukpo Comprehensive Cancer Centre on Monday in Calabar.

The News Agency of Nigeria reports that the outreach, which was held at the premises of the Christian Central Chapel International, Calabar, is part of programmes to commemorate “Movember.”

Movember, which involves the growing of mustaches, is an annual event held in November to raise awareness of men’s health issues such as prostate cancer, testicular cancer, and men’s mental health.

The urologist, who was reacting to claims on social media that constant intimacy and having multiple girlfriends could prevent prostate cancer, said the disease was either hereditary, caused by lifestyle, or environmental.

“Instead of taking unprofessional and unscientific advice from different quarters, it is important to visit a hospital if you notice anything, and for those in their forties and fifties, get screened because early detection is key to effective treatment of cancer.

“Prostate cancer is indolent cancer and can be handled when a man is aware, visits a medical facility, and changes his lifestyle, not by having multiple ‘side chicks,’ he said.

On his part, Mr Yegwa Ukpo, the Executive Director, Asi Ukpo Comprehensive Cancer Centre, said they had to commemorate Movember because men’s health issues were hardly addressed in society.

Represented by Mrs Mercy Njoku, Event and Outreach Manager of the centre, Ukpo said there was something about masculinity in a society that made men think they had to keep their issues to themselves.

“I want to appeal to the men to take their health seriously because cases of men slumping and dying in their forties and fifties are on the increase; we don’t want this to continue.

NAN

In a bold move to address the growing diabetes crisis in Nigeria, EVA Pharma Nigeria officially launched three cutting-edge products aimed at improving the management of diabetes and its complications. The highly anticipated event took place at the Radisson Blu Hotel in Ikeja, Lagos, and was attended by a wide range of healthcare professionals, including renowned experts in endocrinology and orthopaedics. The launch marks a significant step toward making life-saving medications more affordable and accessible to Nigerian patients battling diabetes.

The event featured expert presentations from leading figures in diabetes care, such as Professor Femi Fasanmade, Dr Bolanle Okunowo, Dr Israel Akinmokun, and Dr Yunde Oloyede. They spoke on the challenges of diabetes management in Nigeria and the need for comprehensive approaches that go beyond simply managing blood sugar levels to addressing the debilitating complications of the disease, which include neuropathy, kidney damage, and blindness.

In an exclusive interview with pharmanewsonline, Country Head of EVA Pharma Nigeria, Pharm. David Otokpa, emphasised the company’s mission to provide quality medicines at affordable prices, particularly for people in sub-Saharan Africa who often struggle with the high cost of healthcare.

Breaking barriers to accessing affordable medicines

“EVA Pharma has a long heritage, dating back to 1917, but we only established our presence in Nigeria in 2022,” Pharm. Otokpa explained. “We decided to focus on sub-Saharan Africa because of the urgent need for accessible and affordable medicines. While high-quality medicines are available in the region, the challenge is that they are often priced beyond the reach of many people.”

EVA Pharma, which operates in over 70 countries across Europe, North America, and the Middle East, is committed to addressing the affordability problem that hampers healthcare access in many parts of Africa. Currently, the company is focused on endocrinology, particularly diabetes, metabolic diseases, and virology in Nigeria, with plans to expand into other therapeutic areas in the future.

“Affordability is a key priority for us,” Otokpa continued. “As one of the world’s low-income regions, Nigeria needs affordable healthcare solutions. We are committed to providing the same quality of medicines that are available in developed countries, but at prices that Nigerians can afford.”

Local manufacturing plans in the pipeline

Pharm. Otokpa also discussed EVA Pharma’s plans for local manufacturing in Nigeria. While the company currently imports medicines from its factories in Egypt and Saudi Arabia, it is in talks with local and state governments to establish manufacturing facilities in Nigeria.

“We are in discussions with relevant regulatory bodies and state governments regarding the possibility of setting up local manufacturing,” Otokpa revealed. “However, building a facility that can produce up to one million pharmaceutical products daily is not something that can happen overnight. We are committed to local production, but in the meantime, our products will remain accessible to Nigerian patients.”

Navigating a competitive market

The diabetes medication market in Nigeria is highly competitive, with several multinational and local companies offering treatment options. However, Otokpa remains confident in EVA Pharma’s ability to make a meaningful impact, not by competing with existing companies, but through collaboration and synergy.

“We don’t see other companies as competition in the traditional sense,” Otokpa said. “We believe in collaboration and leveraging what others have done. We are already working with some of the big names in the industry, manufacturing for global brands you might not even expect.”

He added that collaboration creates opportunities for flexibility in pricing, quality, and availability, ultimately benefiting patients. “We all have the same goal: patient care. Competition creates better pricing, better quality, and more options for the people who need it most.”

Innovative products for comprehensive diabetes management

The three products unveiled at the event are designed to treat different forms of diabetes and prevent its complications. One of the key products is Gliptus Plus (Vildagliptine 50 mg + Metformin Hydrochloride 1000 mg), which targets hyperglycemia (high blood sugar). According to Otokpa, while high blood sugar itself is dangerous, the real threat to many diabetic patients lies in the complications it causes, such as neuropathy (nerve damage), kidney failure, and blindness.

To address this, EVA Pharma introduced Thiotacid (Thioctic Acid 600 mg), a product developed to manage diabetic neuropathy, a condition that has no effective treatment options in Nigeria. Thiotacid aims to alleviate symptoms such as numbness and tingling in the extremities and prevent more severe complications like amputations, which are common among diabetic patients with advanced neuropathy.

The third product is Donifoxate (Febuxostat 40 mg), used to manage hyperuricemia, a condition that often coexists with diabetes and can exacerbate complications. These three products represent a holistic approach to diabetes care, focusing not just on controlling blood sugar levels but also on preventing the devastating consequences of the disease.

A message of hope for diabetic patients

Pharm. Otokpa also shared a message of hope for Nigerian patients suffering from diabetes, a disease often considered expensive to manage. “While diabetes can be an expensive condition to treat, we are making it our mission to change that. We want Nigerians to know that they can live normal lives without fear of being overwhelmed by medical bills. In addition to these products, we are working to make insulin available at much more affordable prices in the near future.”

He concluded, “At EVA Pharma, we understand the financial pressures many Nigerian families face, and we are committed to offering high-quality, affordable medications. Our goal is to ensure that diabetes management becomes not just possible, but sustainable for all Nigerians.”

EVA Pharma’s launch of affordable diabetes medications marks a significant milestone in addressing the growing healthcare needs in Nigeria. With a focus on affordability, quality, and collaboration, the company is poised to make a lasting impact on the lives of Nigerians suffering from diabetes and its complications. As the company expands its operations and production capabilities, it promises to deliver even more affordable solutions to one of the most pressing health challenges facing the country today.

-Announces Partnership with Pharmanews

The Pharmaceutical Society of Nigeria-Young Pharmacists Group (PSN-YPG) has congratulated Pharm. (Sir) Ifeanyi Atueyi, publisher and managing director of Pharmanews, on receiving the prestigious Professional Leadership Practitioners’ Institute Award. The award, presented on 7 November, 2024, at the University of Lagos, recognises Atueyi’s transformative leadership in health and wellness innovation.

In a statement signed by the PSN-YPG National Editor-in-Chief, Pharm. David Friday, the group described the award as a testament to Atueyi’s unwavering pursuit of excellence through innovative leadership. The PSN-YPG highlighted his remarkable contributions to the Pharmacy profession, which have inspired countless practitioners and advanced the sector.

The group also announced a new partnership between PSN-YPG and Pharmanews, aimed at amplifying the voices of young pharmacists and providing a platform to showcase their initiatives.

Expressing gratitude for Atueyi’s consistent support, the PSN-YPG group affirmed their commitment to advancing the profession under his mentorship and guidance.

-Honours Atueyi with Distinguished Personality Award

The journey of graphopharmacy in Nigeria has witnessed an astonishing turning point as Macdiptoy Consulting Limited inducted its first batch of graphopharmacists. The event, which was held Thursday, at the Pharmanews Ltd head office, Maryland, Lagos, combined a graduation ceremony and induction, showcasing the pioneering integration of graphology into pharmacy practice for better healthcare delivery.

Graphopharmacy, a concept pioneered by Pharm. Macjob Oladipupo employs handwriting analysis to detect and address health concerns, reforming preventive healthcare in Nigeria. In his presentation at the event, Oladipupo underscored the potential of graphopharmacy in transforming community pharmacy practice, citing its therapeutic value in improving conditions like stroke recovery and mental health.

He further explained that graphopharmacotherapy involves the use of certain tools, that is, writing certain things to help a patients’ condition.

“You can write certain things which we call tools in graphopharmacy. Certain tools can be written that can even help patients that have suffer stroke.”

“If you get stroke patients to write more, you’ll be seeing the improvement in their health as the handwriting smoothens.

The graphopharmacy pioneer asserted that writing stimulates the brain, and could result in longevity in elderly persons. “One of the things we have found out is that the chances of elderly people living longer are more if they are encourage them to write.”

“If you want your elderly people to stay longer, encourage them to write more. Get them to write more. It is an activity that stimulates certain areas in the brain.”

Pharm. (Sir) Ifeanyi Atueyi, the chairman of the occasion and publisher of Pharmanews, was honoured with the Distinguished Personality Award for his lifelong contributions to Pharmacy and Journalism, particularly his mentorship to the graphopharmacy pioneer.

The Octogenarian Publisher, described the initiative as historical and praised Pharm. Oladipupo for leveraging his God-given talent to birth such innovation. “No one has ever done this before in Nigeria. Your determination and resilience have made this possible,” he said.

Reflecting on his path to greatness, he emphasised the need for excellent service as that was his stepping stone to success. “ Nobody can beat his chest and say I made myself.

“I’m thankful to God for who I am today, I thank you for honouring me today”.

The ceremony saw the induction of three Fellows as Nigeria’s first graphopharmacists: Pharm. Adeolupo Mercy Tosin; Pharm. Eseosa Osemwegie; and Pharm. Sanusi Abayomi Musbau. Speaking on behalf of the Fellows, Musbau highlighted the programme’s impact in equipping pharmacists to address health issues with greater precision, while Pharm. Tosin expressed her pride in being a pioneer inductee and her commitment to advancing healthcare outcomes.

The ACPN Chairman, Lagos Chapter, Pharm. Tolulope Ajayi, who was the guest speaker at the occasion, commended the initiative as a ground-breaking step in pharmacy practice and urged the inductees to continually seek personal and professional growth.

“Congratulations on being inducted as the very first set of graphopharmacists in our dear country. It is a unique feat” he said

He continued, “I want to encourage you, please don’t rest on your boars. Keep the fire burning. Keep charging yourself and keep developing. Learning is lifelong. Every avenue and every opportunity to develop, we must embrace it. The truth is we won’t stop learning until we leave this world.”

The Representative of the ACPN National Chairman, Pharm. (Mrs) Mary Omokhafe Ashore, praised the programme’s alignment with global healthcare trends and its focus on holistic, preventive care.

“This proactive solution demonstrates how we can approach healthcare management from a holistic and preventive angle, aligning with the global trend toward integrating health. By studying the unique energy patterns manifested in handwriting, graphopharmacists can identify red flags indicative of both current and potential health challenges. This early detection approach could transform how we diagnose and respond to health concerns promoting wellness in ways that extend beyond conventional methods.” She noted.

she urged the Fellows to stand firm at the frontiers of healthcare delivery. “Your expertise will undoubtedly enrich our healthcare system and offer unique perspectives to your communities, advancing not only individual health but the collective well-being of our society.”

“ I encourage each one of you to continue developing this expertise with humility and commitment. As pioneers, you hold the responsibility to uphold the highest standards in practice, to educate, and to inspire others within and beyond our profession. I am confident that you will uphold this responsibility with excellence.”

A solemn oath swearing marked the induction, which highlighted the ethical standards of precision, care, and confidentiality in graphopharmacy. Oladipupo announced plans for the next training session in March 2025, underlining the need for wider awareness of the practice.

…As May & Baker increases award’s cash reward to N1.5million

A former Dean, Faculty of Pharmacy, University of Ibadan (UI), Professor Oluwatoyin Odeku has won the 2024 edition of the prestigious May & Baker Professional Service Award in Pharmacy.

She was announced the winner of the award at the closing bouquet of the 97^th Annual National Conference of the Pharmaceutical Society of Nigeria (PSN), held from 4-9 November, 2024, in Uyo, Akwa Ibom State.

Meanwhile, pharmacists in academia have dominated the award in the past four years, winning it back to back in 2021, 2022, 2023 and now 2024.

A former National Chairman of the Association of Pharmacists in Academia (NAPA), Prof. Martins Emeje, clinched the award in 2021 in Port Harcourt; Deputy Vice-Chancellor, Academic, University of Benin, Professor Ray Ozolua, won the award in 2022 in Jos. Prof. Emmanuel Chinedum Ibezim, of the Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka emerged the winner of the award in 2023 and now Professor Oluwatoyin Odeku of Faculty of Pharmacy, University of Ibadan (UI), has won the 2024 edition.

While announcing the winner of the award, the chairman of the award committee, Pharm. Anthony Oyawole, who likened the award to the “Nobel Laurel”, noted that the May & Baker Professional Service Award in Pharmacy was instituted in 2005 by May & Baker Nigeria Plc.

He stated that the award was meant to recognise outstanding achievements and contributions by individual practitioners, public servants, industry operators, academicians/researchers in the study and practice of pharmacy in Nigeria.

The award committee chairman expressed profound appreciation to the management of May & Baker Nigeria Plc for sustaining the award since it was established till date. While commending pharmacists in academia for dominating the award, Pharm. Oyawole urged pharmacists in other practice areas to be innovative in their practice so that they can win the subsequent editions.

In his remark, the managing May & Baker PLC, Pharm. Patrick Ajah, commended the award committee for a job well done  over the years. He also commended all the past winners of the award, saying their contributions to the pharmaceutical industry in Nigeria remain indelible.

Meanwhile, the cash value for the award, which is currently N1 Million will be increased to N1.5 Million from the next edition. While announcing the increment of the cash value, Pharm. Ajah said, the value was once N500,000 but was increased to N1million, he averred that in view of the inflation rate in the country, the cash value will be increased to N1.5million from next year.

The managing director added that May & Baker will also partner with the winner of the award henceforth, especially the academia by sponsoring their research works and also ensure that the outcome of the research will be transformed to finished products that will be produced in commercial quantity and make them available in the market.

While speaking to Pharmanews on the award, professor Odeku commended the management of May & Baker for their consistency in recognising valuable contributions to the pharmaceutical sector.

She said “I count it a great honour to be the recipient of the 2024 May and Baker professional service award. I am grateful to God and my family for their support. I appreciate May and Baker for consistently recognising contributions to the profession of pharmacy over the years. I wish May and Baker continuous success”.

The May & Baker Professional Service Award in Pharmacy is one of the most prestigious awards in the Pharmacy profession in Nigeria and prominent pharmacists have won the award over the years.

The past winners of the award include Pharm. (Lady) Adaeze Omaliko, managing director of Malix Pharmacy, Onitsha; Professor (Mrs) Mbang Femi-Oyewo, former deputy vice chancellor of Olabisi Onabanjo University; Pharm. Ifeanyi Atueyi, managing director of Pharmanews Limited; Pharm (Mrs) Margaret Obono, a Fellow of the Pharmaceutical Society of Nigeria (PSN); and Pharm. Folashade Lawal, a renowned community pharmacist, among others.

The Nigerian Meteorological Agency has issued a weather forecast indicating the likelihood of dust haze and rain nationwide from Monday to Wednesday.

NiMet’s weather outlook released on Sunday in Abuja envisaged a slight dust haze on Monday with localised visibility of 2 km to 5km in the northern region during the forecast hours.

“In the North Central region, slight dust haze with localised visibility of 2km to 5km is expected during the forecast period.

“In the South, sunny skies in a hazy atmosphere are expected over the inland, with prospects of thunderstorms with slight rains anticipated over parts of Lagos, Akwa Ibom, and Cross River States in the morning.

“Towards the afternoon/evening hours thunderstorms with slight rains are expected over parts of southern Ondo, Ogun, Lagos, Edo, Cross River, Akwa Ibom, Bayelsa, Rivers, and Delta States,” it said.

The agency predicted a slight dust haze on Tuesday with localised visibility of 2km to 5km during the forecast hours in the northern region.

According to NiMet, a slight dust haze with localised visibility of 2km 5km is expected during the forecast period in the North Central region.

It anticipated sunny and hazy skies over the inland and patches of clouds over the coastal states during the forecast period in the southern region.

The agency forecasts slight dust haze with localised visibility of 2km to 5km during the forecast hours in the northern region on Wednesday.

”In the North Central region, slight dust haze with localised visibility of 2km to 5km is expected during the forecast period.

“In the southern region, sunny and hazy skies are anticipated over the Inland while patches of clouds are expected over the coastal States.

” Later in the day, thunderstorms with moderate rains are anticipated over parts of Lagos, Cross River, Rivers, Bayelsa, and Akwa Ibom States,” it said.

NiMet urged the public to take necessary precautions as dust particles are in suspension.

It advised people with asthmatic health conditions and other respiratory issues to be cautious of the present weather conditions.

“Strong winds may precede the rains in areas where thunderstorms are likely to occur, so the public should take adequate precautions.

“Adhere to safety advisories issued by relevant authorities.

“‘Airline operators are advised to get airport-specific weather reports (flight documentation) from NiMet for effective planning in their operations.

“Residents are advised to stay informed through weather updates from NiMet”, it said.

NAN

Stakeholders in the health sector have hailed the Federal Government’s free Caesarean Section initiative for pregnant women, describing it as a critical move toward reducing preventable maternal deaths.

The stakeholders commended the programme while speaking with the News Agency of Nigeria on Sunday in Abuja.

NAN reports that the Federal Government unveiled a nationwide free C-Section initiative aimed at reducing Nigeria’s alarming maternal mortality rates.

The Coordinating Minister of Health and Social Welfare, Prof. Muhammad Pate, announced the initiative at the three-day Health Sector-Wide Joint Annual Review which ended on Friday.

According to him, under the initiative, C-sections and essential maternal care would be provided free of charge to eligible women across the country, targeting areas with the highest maternal deaths.

A maternal and reproductive health advocate, Dr Ejike Oji, emphasised the need for a holistic approach to ensure the programme’s success.

“When I conceptualised the Midwifery Service Scheme years ago, I was disheartened by the high maternal mortality rate.

“Nearly 80 per cent of women deliver in rural areas where skilled attendants are scarce, making them vulnerable if complications arise.”

Oji said with free C-sections, women could receive timely surgical intervention without financial strain.

He stressed that public education and community engagement were essential to reach these women before emergencies occurred.

Oji, who is the chairman, Association of the Advancement of Family Planning, stressed the need for an informed healthcare workforce and better infrastructure, particularly in rural Primary Healthcare Centres.

He called for community awareness campaigns to inform women about the availability of free C-sections, as well as the strengthening of referral systems to facilitate timely transfers from rural PHCs to better-equipped facilities.

“This programme will only succeed if the referral system is efficient, linking primary centres to secondary and tertiary facilities,” he noted.

Oji also emphasised the media’s role in raising awareness and mobilising communities.

He added that delivering information to rural areas through accessible media channels would ensure that families understand the availability of free C-sections and seek timely care.

On his part, the Managing Director, Society for Family Health, Dr Omokhudu Idogho, said that the policy was transformative and removed financial barriers.

He, however, said that it was more critical to get women into facilities in the first place through Antenatal Care and community outreach.

According to him, without access to comprehensive ANC, the healthcare system cannot anticipate complications requiring C-sections.

To bridge the gaps, he suggested that healthcare organisations continued working within communities to remove barriers, especially in rural areas.

He highlighted the importance of addressing delays in recognising danger signs, reaching health facilities, and receiving care at facilities as the “three delays” that lead to maternal mortality.

Idogho also pointed out the significance of integrating private healthcare providers into the programme, as a substantial number of Nigerians relied on private healthcare services.

He suggested a voucher system to allow women to access C-sections at private facilities if needed.

“Incorporating the private sector is essential to expand reach.

“If we address both public and private sectors effectively, we can see up to a 70 per cent reduction in maternal mortality, transforming maternal health in Nigeria.”

NAN

The newly elected President of the Pharmaceutical Society of Nigeria (PSN), Pharm. Ibrahim Tanko Ayuba, has pledged to make good his campaign promises to pharmacists, as he appreciated all that made his emergence a possibility.

Ayuba made this statement in his first address to pharmacists after he was declared winner of the very competitive presidential election, that took place 97th Annual National Conference of PSN, in Uyo, Akwa Ibom State.

He also declared his administration an all- inclusive one, that will ensure no pharmacist is oppressed or discriminated against. He said unity among pharmacists will be a major driver of his tenure.

He said, “During the run-up to the elections, we promised to carry out a number of programmes, projects, and advocacy initiatives that will not only sustain the remarkable strides achieved by my predecessors, but will also enhance the value and visibility of the Nigerian pharmacist within the healthcare delivery space.

“You can hold me accountable for these promises,” he avowed.

The new helms man of PSN, who termed his government as ‘Our Presidency”, expressed his appreciation to his supporters who gave him their mandate, assuring them of his capacity to deliver a progressive PSN in the shortest possible period.

He acknowledge the magnitude of the task ahead of him, especially with myriads of threats to the profession in Nigeria, He however, assured them of what he possesses in terms of capacity, competence, and connections that will ensure the years of relegating pharmacists and Pharmacy profession to the background are over.

He further buttressed on his agenda for the Society thus, ”To achieve, and indeed, exceed our goals and campaign promises, unity within our team and the Society remains a key driver that we must keep in focus. We are a PHARMILY.

“This is why I have called this our presidency. It is our presidency because the PSN belongs to all of us!

“It is our presidency because we shall be building and rebuilding bridges, and also mending fences.

“It is our presidency because there are no victors or losers! With me, Pharmacy wins all the time. It is our presidency because I shall run an all-inclusive government, where no Nigerian pharmacist shall be oppressed or discriminated against.

“It is our presidency because I shall be your servant leader. It is our presidency because we shall continuously subject ourselves to your scrutiny for accountability, integrity, and performance.”

The number-one pharmacist in Nigeria expressed his appreciation to the Immediate Past President, Pharm. (Prof.) Cyril Odianose Usifoh, for the provision of quality leadership over the years, and creation of a level playing ground in the last three years for all actors to express their aspirations.

In response to the recent surge in Mpox cases across Africa, the Access and Allocation Mechanism has allocated a batch of 899,000 vaccine doses to nine African countries severely impacted by the outbreak.

This joint initiative, launched by the Africa Centre for Disease Control and Prevention (Africa CDC), the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance, UNICEF, and the World Health Organisation (WHO), aims to curb the spread of Mpox by prioritising regions with the highest transmission rates.

According to a joint press release from these agencies, this collaboration seeks to ensure that the limited vaccine doses are used fairly and effectively, based on epidemiological data of each country.

The nine countries set to receive vaccine doses include the Central African Republic, Côte d’Ivoire, the Democratic Republic of the Congo (DRC), Kenya, Liberia, Nigeria, Rwanda, South Africa, and Uganda.

The DRC, which remains the epicentre of the outbreak, is expected to receive 85 percent of the allocation, as it has reported four out of every five confirmed cases in Africa this year. “The scale of the outbreak in the DRC underscores the urgency of focused vaccine distribution in the region,” the release highlighted, noting that these countries’ allocations aim to address the worst-hit areas.

These doses have been secured through donations from Canada, Gavi, the European Union (EU), and the United States, with contributions coming from EU member states, including Austria, Belgium, Croatia, France, Germany, and Spain, as well as from the United States and Canada. In light of the rapid spread of the clade Ib strain of Mpox, the vaccination programme marks a coordinated approach to address the outbreak, which has affected 19 African countries, many experiencing cases for the first time.

Declared a public health emergency of international concern by WHO and a public health emergency of continental security by Africa CDC in August, the Mpox outbreak has led to more than 38,000 suspected cases and over 1,000 deaths in the DRC alone this year. Africa CDC affirmed that vaccination is a key component of the broader Mpox response strategy, which also includes testing, clinical care, infection prevention, and community engagement.

According to the statement, the phased vaccination strategy targets three stages wherein Phase 1 aims to vaccinate approximately 1.4 million individuals at risk by the end of 2024, using 2.8 million doses of the MVA-BN vaccine.

“By focusing initially on those at greatest risk of exposure, we aim to interrupt transmission in the areas with the highest case counts.”

“Subsequent phases of the rollout will expand to cover additional high-risk populations as more doses become available. Phase 2 focuses on protecting individuals at risk of severe disease, including vulnerable groups like people living with HIV, internally displaced persons, and refugees in affected regions. Phase 3 aims to build population immunity as a preventive measure against future outbreaks, establishing long-term protection in communities. As doses increase, we will prioritise protection for high-risk populations to support longer-term outbreak control.” the statement reads.

The National Primary Health Care Development Agency says it has unveiled a new comprehensive funding model and enhanced oversight mechanisms to revitalise Primary Health Care Centres across Nigeria.

Its Executive Director, Dr Muyi Aina, disclosed this during the inauguration of the Basic Health Care Provision Fund held on Thursday in Abuja.

Aina said the move was aimed at evaluating progress across the health sector, focusing primarily on the effectiveness of the Sector-Wide Approach (SWAp).

The News Agency of Nigeria reports that Joint Annual Review serves as a vital platform for driving the Sector Wide Approach in the country.

It unites key stakeholders to assess progress, address challenges, and pinpoint opportunities for improvement.

It also reflects on achievements, openly discussing challenges and identifying areas for improvement, creating a constructive space for aligning on what matters most: improving health outcomes for all Nigerians.

Aina said BHCPF reforms are equally aimed at addressing long-standing issues of inadequate funding, mismanagement and inefficiency that have plagued Nigeria’s PHC system.

He stressed that the new reforms focus on improving access to healthcare services, ensuring the effective use of resources and increasing accountability at the local government level.

According to him, the BHCPF reforms introduce a revamped funding structure that prioritises direct allocations to PHCs, with strict financial oversight aimed at curbing waste and corruption.

“This new funding model will ensure that resources are allocated directly to the PHCs based on performance, patient outcomes and facility requirements.

“For the first time, local governments will have a significant role in the allocation and monitoring of these funds, which will make sure that the resources are spent where they are most needed,” he said.

According to him, the BHCPF 2.0 initiative is expected to address the gaps in the delivery of essential health services, including maternal and child health, immunisation and the treatment of common diseases such as malaria and tuberculosis.

He said that the new model also focuses on the integration of digital technologies for monitoring health services and strengthening data collection, reporting and transparency.

“A key aspect of the reforms is the establishment of an independent oversight committee that will monitor the proper utilisation of the funds at the grassroots level.

“This will ensure that financial and operational accountability is upheld and that the PHCs meet the standards required to deliver quality healthcare.

“The unveiling of the BHCPF 2.0 reforms is part of the ongoing efforts by the Nigerian government to boost the effectiveness of its healthcare system and improve the lives of millions of Nigerians in underserved communities.

“The initiative will also enable greater public and private sector collaboration in improving healthcare infrastructure and services,” he said.

Similarly, Dr Bolanle Olusola-Faleye, Chief of Party, USAID Local Health System Sustainability Project (LHSS), said the success of the initiative would depend on its effective implementation at the local level.

Olusola-Faleye said if local communities are fully involved and there is robust monitoring, the funding model could set the stage for transforming Nigeria’s healthcare delivery system.

“The NPHCDA has committed to ongoing engagement with state and local government authorities to ensure the reforms’ seamless rollout.

“In addition, it highlights that continuous training for healthcare workers will be essential to maximise the impact of the BHCPF 2.0 reforms on patient care,” she said.

She said that Nigeria hopes to make significant strides towards achieving Universal Health Coverage (UHC) and improving the overall health outcome of its population, particularly those in rural and underserved areas.

NAN reports that several local and international stakeholders, including donors and civil society organisations, were present at the inauguration, as some stressed the importance of community engagement in the anticipated success of the reforms.

NAN

To address some of the lingering challenges bedeviling healthcare in the country, eminent pharmacists and stakeholders at the 97th annual Pharmaceutical Society of Nigeria (PSN) conference in Uyo have urged Nigerian pharmacists to adopt a value-based approach to healthcare, especially in chronic diseases management and preventive care.

Speaking during the first plenary session at the conference, chaired by Hajia Wosilatu Giwa, PCN chairman, which featured impactful contributions from Pharm. (Dr) Teresa Pounds, chairman, West African Society of Parenteral and Enteral Nutrition (WASPEN); Pharm. Wale Oladigbolu, immediate past national chairman, ACPN, and Pharm. (Mrs) Abimbola Adebakin, CEO, Advantage Health Africa, the speakers stressed on the urgent need for a transformative shift in pharmacy practice across Nigeria.

Setting the tone, Giwa highlighted the power of digital innovation to reshape Nigeria’s healthcare landscape, particularly by harnessing tools like electronic health records, telemedicine, and artificial intelligence.

She noted that these technologies could improve healthcare access and efficiency, especially in underserved communities, and called on pharmacists to engage with these advancements. “Digital transformation can drive operational efficiency, lower costs, and boost economic growth, ultimately creating a healthier and more prosperous society,” she stated.

Dr Pounds, as the lead speaker, introduced a comprehensive model for value-based care, advocating for a departure from the traditional fee-for-service approach in favour of a system focused on patient outcomes.

Pounds further outlined how value-based care could allow pharmacists, especially in community settings, to provide medication therapy management, personalised wellness consultations, and patient-centred care, ultimately reducing costs while enhancing patient satisfaction. She described the Management Service Organisation (MSO) model, which allocates administrative functions separately from clinical services, enabling pharmacists to dedicate more time to direct patient care.

Speaking further, Pounds highlighted the success of a pilot programme involving pharmacists equipped with Trust Rx technology, a system that enables patient assessments and continuous health monitoring, particularly for managing chronic conditions such as hypertension and diabetes. She encouraged Nigerian pharmacists to consider such value-based models to drive healthcare improvement across the country.

In his own speech, Pharm. Wale Oladigbolu underscored the unique position of community pharmacies in Nigeria, where over 70 percent of citizens access healthcare through the private sector, arguing that community pharmacies have the potential to bridge gaps left by under-resourced primary healthcare facilities, particularly in terms of access and affordability.

He cited recent policy advances, such as the federal endorsement of pharmacy-administered vaccination services, which have supported community pharmacies in delivering essential health services.

Oladigbolu emphasised that pharmacists must transition from mere dispensers to proactive healthcare providers, equipped with new skills in areas like point-of-care testing and chronic disease management. “This transformation will not only benefit patients but also help pharmacists to progress in their careers through continuous upskilling and stakeholder engagement,” he noted.

In her contribution, Pharm. Abimbola Adebakin, urged pharmacists to embrace their roles as influential healthcare providers, likening them to “princes” in the sector. She challenged pharmacists to recognise their unique advantage of direct patient access and use it as an opportunity to offer personalised, value-based care.

Adebakin cited the growing trend of social media as an untapped platform for pharmacists to share valuable health insights and connect with broader audiences, particularly on chronic diseases management.

“We must move beyond competing on price alone,” Adebakin advised, stressing the potential for pharmacists to introduce subscription models for ongoing care and develop deeper, long-lasting relationships with their patients. Her message to fellow pharmacists was clear: “Tell yourself, I am valuable,” she concluded, urging them to take ownership of their role as essential healthcare influencers in Nigeria.

The speakers, unanimously called for collective action among Nigerian pharmacists to adopt value-based care practices, digital integration, and continuous professional development, aimed at delivering quality care to communities and meeting the nation’s rising healthcare needs.

Seagreen Pharmaceuticals, a sister company to Greenlife Pharmaceuticals, has officially reintroduced Amino Pep Forte, the popular amino acid and multivitamin supplement, at the 97th Annual National Conference of the Pharmaceutical Society of Nigeria (PSN) in Uyo, Akwa Ibom State.

The relaunch, held during the first plenary session of the PSN event, marks Seagreen’s strategic commitment to expanding access to essential health supplements in Nigeria.

Speaking during the unveiling, Mrs Evelyn Okorie, marketing manager for Seagreen Pharmaceuticals, shared her enthusiasm for re-establishing Amino Pep Forte in the Nigerian market. She highlighted the product’s enriched formulation, which combines ten essential amino acids, multivitamins, and zinc. It is designed to bolster immune function, support post-surgical recovery, aid in growth, and promote general wellness across age groups.

“Amino Pep Forte is truly a product for everyone, mama, papa, and pikin,” Okorie remarked, describing the supplement’s versatility in supporting immune health, cell regeneration, and faster recovery. “With amino acids critical for protein synthesis and zinc aiding in wound healing and reducing oxidative stress, Amino Pep Forte addresses a range of health needs, including chronic conditions like diabetes and hypertension.”

Okorie reassured PSN members that Seagreen Pharmaceuticals is committed to overcoming past distribution challenges to ensure Amino Pep Forte is available nationwide. “Seagreen is dedicated to maintaining the highest standards of quality and ensuring Amino Pep Forte becomes the primary choice for amino acid and multivitamin supplementation in Nigeria,” she added.

Adding a significant endorsement, the Chairman of the Pharmacy Council of Nigeria (PCN), Pharm. (Hajia) Wosilatu Giwa, praised the product’s return and commended Seagreen Pharmaceuticals for its dedication to accessible, high-quality healthcare solutions.

“Today, it is my pleasure to reintroduce Amino Pep Forte, a brand trusted by Nigerian households and healthcare professionals alike,” Hajia Giwa stated. “Although it may have left the market temporarily, its legacy of quality and reliability remains strong. With Seagreen at the helm, Amino Pep Forte has not only been rebranded and repackaged but is now supported by a company committed to addressing the health needs of Nigerians.”

Representing the PSN’s vision, Giwa emphasised that the organisation has always supported the promotion of pharmaceuticals that benefit public health, adding that Amino Pep Forte aligns with that mission. “I am confident that Seagreen’s dedication will ensure Amino Pep Forte reaches more homes, clinics, and pharmacies across Nigeria, contributing to a healthier population,” she said.

To mark the relaunch, Giwa invited past and present PSN leaders to join in the product unveiling, with the crowd enthusiastically chanting, “Amino Pep 10 over 10,” celebrating its comprehensive amino acid profile and renewed place in the Nigerian market.

Mr Wasiu Adelodun, national sales manager for Seagreen, also spoke on the relaunch, affirming that Amino Pep Forte is poised to reclaim its status as a trusted supplement. “With this reintroduction, Amino Pep Forte will once again provide the essential nutrients that support immunity, recovery, and overall health for Nigerians of all ages,” Adelodun stated.